CPHA Canvax

The Public Health Agency of Canada (PHAC) Vaccine Confidence InfoBulletin provides credible and timely information on vaccines to health care providers and public health decision makers to support vaccine confidence.


Volume 2 I Issue 10 I November 2022 I Public Health Agency of Canada (PHAC)

Issue highlights:

  • NACI recommendations on: 
    • The use of Pfizer-BioNTech Comirnaty® (3mcg) COVID-19 vaccine in children 6 months to 4 years of age
    • Pfizer-BioNTech Comirnaty® BA.4/5 Bivalent (30 mcg) COVID-19 vaccine authorization
    • Updated guidance on the use of COVID-19 vaccine booster doses in Canada
    • Updated interim guidance on Imvamune® in the context of ongoing monkeypox outbreaks
  •  Q&A on the use of COVID-19 bivalent Omicron-spike containing booster doses
  • The on-going evolution of the SARS-CoV-2 virus
  • Comparison table of the Moderna Spikevax™ and Pfizer-BioNTech Comirnaty® COVID-19 vaccines
  • Ma Mawi Wi Chi Itata Centre – Protecting our future

Read more: Click Here

November EN

 

Volume 2 I Issue 9 I September 2022 I Public Health Agency of Canada (PHAC)

Issue highlights:

  • Recommendations on the use of a first booster dose of Pfizer-BioNtech  Comirnaty® COVID-19 vaccine in children 5 to 11 years
  • Recommendations on the use of bivalent Omicron containing mRNA COVID-19 vaccines
  • Leveraging lessons learned from projects funded by the PHAC Immunization Partnership Fund (IPF) to support seasonal influenza vaccine uptake
  • Hybrid immunity and COVID-19
  • Comparison table of the Moderna Spikevax™ COVID-19 vaccines
  • Digital Public Square (DPS) – combating mis/disinformation through gamification

Read more: Click Here

September 2022 - bulletin 9

 

Volume 2 I Issue 8 I August 2022 I Public Health Agency of Canada (PHAC)

Issue highlights:

  • Meningococcal outbreaks in Florida
  • Case of polio confirmed in New York State
  • Impact of COVID-19 on routine childhood vaccinations
  • Evidence-informed strategies for building vaccine confidence among caregivers of children
  • Human papillomavirus (HPV) vaccination misinformation
  • Measles infection and the immune system
  • Updated guidance on concurrent administration of COVID-19 vaccines for children 5 to 11 years of age

Read more: Click Here

VCIB_August

 

Volume 2 I Issue 7.1 I July 2022 I Public Health Agency of Canada (PHAC)

Issue highlights:

  • NACI guidance summary: Moderna SpikevaxTM COVID-19 vaccine in children 6 months to 5 years of age 
  • Practical vaccine administration information
  • Managing pain for a positive vaccination experience
  • Anxiety-related adverse events and anaphylaxis following vaccination

Read more: Click Here

July_IM_EN

 

Volume 2 I Issue 6 I June 2022 I Public Health Agency of Canada (PHAC)

Issue highlights:

  • Global monkeypox virus (MPXV) outbreak
  • Global measles outbreak
  • Misinformation regarding acute severe hepatitis in children
  • Ring vaccination strategies for outbreak containment
  • Vaccine confidence through social mobilization

Read more: Click Here

Issue 6 EN

 

Volume 2 I Issue 5 I May 2022 I Public Health Agency of Canada (PHAC)

Issue highlights:

  • Influenza activity in Canada
  • Are any vaccines vegan?
  • The role of cognitive bias in vaccine attitudes: optimism bias
  • Social media, mis/disinformation, and the vaccine continuum
  • Vaccine-induced passive immunity from human milk and transplacental antibody transfer during pregnancy
  • The Canadian Immunization Guide: an introduction for health care professionals

Read more: Click Here

Cover

 

 

Volume 2 I Issue 4.1 I April 2022 I Public Health Agency of Canada (PHAC)

Issue highlights:

  • Quick reference table: NACI COVID-19 vaccine booster dose recommendations
  • NACI’s updated recommendations on the use of first COVID-19 booster doses in adolescents and adults
  • NACI’s initial guidance on the use of second COVID-19 vaccine booster doses in older adults 
  • The science of decreasing vaccine effectiveness and boosters (republished from Vol 2, Issue 2)
  • FAQs on booster doses

Read more: Click Here

PHAC Infobulletin 4.1

 

Volume 2 I Issue 4 I April 2022 I Public Health Agency of Canada (PHAC)

Issue highlights:

  • NACI’s updated recommendations on the use of COVID-19 booster doses in adolescents and adults
  • NACI’s initial guidance on the use of second COVID-19 vaccine booster doses in older adults 
  • Q&A with Chief Public Health Officer Dr. Theresa Tam on the state of vaccine confidence in Canada 
  • Vaccine effectiveness for pediatric COVID-19 vaccines
  • How to discuss COVID-19 vaccines with parents in the context of low pediatric vaccine effectiveness
  • Pfizer-BioNTech Comirnaty® grey cap re-formulation

Read more: Click Here

Cover

 

Volume 2 I Issue 3 I March 2022 I Public Health Agency of Canada (PHAC)

Issue highlights:

  • Resources for National Immunization Awareness Week
  • Medicago Covifenz® and Novavax Nuvaxovid™ COVID-19 vaccine authorizations and recommendations
  • The role of cognitive bias in vaccine attitudes: omission bias
  • The role of COVID-19 vaccines in the transition towards an endemic state

Read more: Click Here

Cover

 

Volume 2 | Issue 2.1 | February 2022 | Public Health Agency of Canada (PHAC)

Issue highlights: 

  • COVID-19 mRNA booster doses
  • Vaccine confidence in both mRNA COVID-19 vaccines as booster doses
  • Timing of COVID-19 vaccination following SARS-CoV-2 infection

Read more: Click Here

Cover

 

Volume 2 | Issue 2 | February 2022 | Public Health Agency of Canada (PHAC)

Issue highlights:

  • Vaccination after COVID-19 infection
  • Moderna COVID-19 boosters & vaccine hesitancy
  • Pre-print studies & misinformation
  • The science of decreasing vaccine effectiveness and boosters
  • Omicron report & vaccination updates

Read more: Click Here

Cover

 

Volume 2 | Issue 1 | January 2022 | Public Health Agency of Canada (PHAC)

Issue highlights:

  • COVID-19 pediatric infection & hospitalization in Canada
  • COVID-19 vaccination urged for people who are pregnant 
  • The role of cognitive bias in vaccine attitudes: anchoring bias & base rate fallacy
  • The science of vaccine intervals
  • Omicron and COVID-19 vaccine effectiveness

Read more: Click Here

cover

 

Main navigation